APA (7th ed.) Citation

A, A., T, S., J, M., L, H., B, A., J, L., . . . S, R. (2026). Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer. Research square. https://doi.org/10.21203/rs.3.rs-10042173/v1

Chicago Style (17th ed.) Citation

A, Armstrong, et al. "Clinical and Genomic Predictors of Sipuleucel-T Outcomes in Men with Metastatic Androgen Pathway Modulator Resistant Prostate Cancer." Research Square 2026. https://doi.org/10.21203/rs.3.rs-10042173/v1.

MLA (9th ed.) Citation

A, Armstrong, et al. "Clinical and Genomic Predictors of Sipuleucel-T Outcomes in Men with Metastatic Androgen Pathway Modulator Resistant Prostate Cancer." Research Square, 2026, https://doi.org/10.21203/rs.3.rs-10042173/v1.